Decoding Disruptors: Cindy Eckert, CEO at The Pink Ceiling

Decoding Disruptors takes a deep dive into the minds of extraordinary women who have disrupted the narrative in their businesses, industries, and communities.  The team at Finding Mastery, Compete to Create, and Microsoft worked together to bring this series to life.  I had the chance to interview 9 amazing women, every conversation was filmed, and is currently available at decodingdisruptors.com. On the website you’ll also find a Disruptor Assessment— this quick assessment tool will help you measure your mindset skills and illuminates where you are on the road to becoming a disruptive business leader. We’re making a few of these conversations also available on the Finding Mastery podcast feed and this second conversation is with Cindy Eckert, a self-made serial entrepreneur. In the past ten years, Cindy has founded and sold two billion dollar pharmaceutical businesses. A modern day Erin Brockovich, Cindy took on the FDA – and won – to get approval of the first ever drug for low sexual desire in women, dubbed the “female Viagra” by the media. At the time, there were 26 drugs on the market for low sexual desire for men and not a single one for women. The drug was initially rejected by the FDA despite the data and science that supported its need and efficacy... In Cindy’s view, she had to battle a gender bias in healthcare that wasn’t about whether women needed drugs for low libido, but “does women’s sexual pleasure even matter”.  Cindy’s company, The Pink Ceiling, champions the interests of women through its “Pinkubator”, providing funding and mentoring to help female entrepreneurs break through the “pink ceiling.” If there’s a rule that exists for no reason other than a societal narrative, Cindy will break it – and she’ll do it wearing blazing hot pink.  See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.